Journal
CHEMICAL & PHARMACEUTICAL BULLETIN
Volume 53, Issue 8, Pages 965-973Publisher
PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/cpb.53.965
Keywords
lipoxygenase; inhibitor; structure-activity relationship; leukotriene; unsymmetric thioether
Ask authors/readers for more resources
Structural modification of imidazole 5-lipoxygenase (5-LO) inhibitors for optimizing inhibitory potency, pharmacokinetic behavior and toxicity (ocular) profile led to 4-{3-[4-(2-methyl-1H-imidazol-1-yl)phenylthiol}phenyl-3,4,5,6-tetrahydro-2H-pyran-4-carboxamide (6) with no observable ocular toxicity. The orally active and safe imidazole 5-LO inhibitor 6 was selected as a clinical candidate and advanced to clinical studies. An improved synthesis of 6 is also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available